A trial of a combination therapy of fecal microbial transplantation and antibiotics for inflammatory bowel disease

A trial of a combination therapy of fecal microbial transplantation and antibiotics for inflammatory bowel disease - A trial of a combination therapy of fecal microbial transplantation and antibiotics for inflammatory bowel disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025846

Enrollment

Registered

2017-02-01

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis, Crohn&#39

Interventions

Administration of the fecal material from healthy donors to patients after taking three kinds of antibiotics (Amoxicillin, fosmycin, metronidazole) for two weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients with ulcerative colitis and crohn's diseases 2. Healthy adults are selected as donors

Exclusion criteria

Exclusion criteria: 1. Patients who have severe drug allergy are excluded. 2. Donors who show abnormal findings to the screening tests including blood and feces.

Design outcomes

Primary

Measure	Time frame
efficacy, analysis of microbiota	—

Countries

Japan

Contacts

Public ContactDai Ishikawa

Juntendo university school of medicine Department of gastroenterology

dai@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026